3 ms·
There have been other studies. Here's a summary.[1] From the current data, we can conclude that the tetrahydrocannabinol (THC) component of cannabis can be the
by Animats 5y ago
There have been other studies. Here's a summary.[1]
From the current data, we can conclude that the tetrahydrocannabinol (THC) component of cannabis can be the main culprit causing psychosis and schizophrenia in the at-risk population. THC can also be the one exacerbating symptoms and causing an adverse prognosis in already diagnosed patients. Even though CBD shows therapeutic effects and THC opposing effects, the data is minimal and low safety and efficacy warrants more research. The relation between cannabis and schizophrenia needs further investigation. We need more case-control studies and clinical trials with a larger population to get conclusive data.
So, something seems to be going on, but there's not enough data yet.
Years from now, the cannabis industry may face the product liability problems the tobacco industry did in the past, and the vaping industry is facing now.[2]
[1] https://pubmed.ncbi.nlm.nih.gov/32839678/ https://pubmed.ncbi.nlm.nih.gov/32839678/
[2] https://www.cand.uscourts.gov/judges/orrick-william-h-who/in-re-juul-labs-inc-marketing-sales-practices-products-liability-litigation/ https://www.cand.uscourts.gov/judges/orrick-william-h-who/in...
- deleted 5y ago[deleted]